BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24782566)

  • 1. The DEAH-box RNA helicase DHX15 activates NF-κB and MAPK signaling downstream of MAVS during antiviral responses.
    Mosallanejad K; Sekine Y; Ishikura-Kinoshita S; Kumagai K; Nagano T; Matsuzawa A; Takeda K; Naguro I; Ichijo H
    Sci Signal; 2014 Apr; 7(323):ra40. PubMed ID: 24782566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF5 is a downstream target of MAVS in antiviral innate immune signaling.
    Tang ED; Wang CY
    PLoS One; 2010 Feb; 5(2):e9172. PubMed ID: 20161788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling.
    Koshiba T; Yasukawa K; Yanagi Y; Kawabata S
    Sci Signal; 2011 Feb; 4(158):ra7. PubMed ID: 21285412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of MDA5-MAVS Antiviral Signaling Axis by TRIM25 through TRAF6-Mediated NF-κB Activation.
    Lee NR; Kim HI; Choi MS; Yi CM; Inn KS
    Mol Cells; 2015 Sep; 38(9):759-64. PubMed ID: 26299329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHX15 Is a Coreceptor for RLR Signaling That Promotes Antiviral Defense Against RNA Virus Infection.
    Pattabhi S; Knoll ML; Gale M; Loo YM
    J Interferon Cytokine Res; 2019 Jun; 39(6):331-346. PubMed ID: 31090472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex.
    Cao Z; Xia Z; Zhou Y; Yang X; Hao H; Peng N; Liu S; Zhu Y
    Sci Rep; 2016 Sep; 6():33557. PubMed ID: 27629939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAVS-mediated host cell defense is inhibited by Borna disease virus.
    Li Y; Song W; Wu J; Zhang Q; He J; Li A; Qian J; Zhai A; Hu Y; Kao W; Wei L; Zhang F; Xu D
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1546-55. PubMed ID: 23702035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.
    Meylan E; Curran J; Hofmann K; Moradpour D; Binder M; Bartenschlager R; Tschopp J
    Nature; 2005 Oct; 437(7062):1167-72. PubMed ID: 16177806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible cAMP early repressor (ICER) is a novel regulator of RIG-I mediated IFN-β production.
    Johnsen IB; Bergstroem B; Stiberg KA; Thommesen L; Anthonsen MW
    Cell Signal; 2013 Sep; 25(9):1804-12. PubMed ID: 23707530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
    He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
    J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation.
    Wang Y; Tong X; Ye X
    J Immunol; 2012 Dec; 189(11):5304-13. PubMed ID: 23087404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitofusin 2 inhibits mitochondrial antiviral signaling.
    Yasukawa K; Oshiumi H; Takeda M; Ishihara N; Yanagi Y; Seya T; Kawabata S; Koshiba T
    Sci Signal; 2009 Aug; 2(84):ra47. PubMed ID: 19690333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAVS splicing variants associated with TRAF3 and TRAF6 in NF-κB and IRF3 signaling pathway in large yellow croaker Larimichthys crocea.
    Zou PF; Tang JC; Li Y; Feng JJ; Zhang ZP; Wang YL
    Dev Comp Immunol; 2021 Aug; 121():104076. PubMed ID: 33766586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling.
    Miyashita M; Oshiumi H; Matsumoto M; Seya T
    Mol Cell Biol; 2011 Sep; 31(18):3802-19. PubMed ID: 21791617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome.
    Cao Z; Zhou Y; Zhu S; Feng J; Chen X; Liu S; Peng N; Yang X; Xu G; Zhu Y
    Sci Rep; 2016 Feb; 6():22002. PubMed ID: 26906558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VISA is an adapter protein required for virus-triggered IFN-beta signaling.
    Xu LG; Wang YY; Han KJ; Li LY; Zhai Z; Shu HB
    Mol Cell; 2005 Sep; 19(6):727-40. PubMed ID: 16153868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors.
    Castanier C; Zemirli N; Portier A; Garcin D; Bidère N; Vazquez A; Arnoult D
    BMC Biol; 2012 May; 10():44. PubMed ID: 22626058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway.
    Yoshida R; Takaesu G; Yoshida H; Okamoto F; Yoshioka T; Choi Y; Akira S; Kawai T; Yoshimura A; Kobayashi T
    J Biol Chem; 2008 Dec; 283(52):36211-20. PubMed ID: 18984593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter.
    Paz S; Vilasco M; Arguello M; Sun Q; Lacoste J; Nguyen TL; Zhao T; Shestakova EA; Zaari S; Bibeau-Poirier A; Servant MJ; Lin R; Meurs EF; Hiscott J
    Mol Cell Biol; 2009 Jun; 29(12):3401-12. PubMed ID: 19380491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.